Lifestyle & Wellness
-
Young Adults Developing Diabetic Retinopathy Within Just 3–5 Years of Diagnosis, Warn Eye Specialists
MUMBAI : Ophthalmologists are raising concern over the increasing incidence of diabetic retinopathy among young adults, with cases now being detected within just three to five years of a diabetes diagnosis. Once considered a condition…
-
Vidal Health and Serum Institute of India collaborate on HPV Vaccine access
New Delhi : In a step towards preventive and digital-first healthcare, Vidal Health, India’s second largest TPA service provider and Serum Institute of India (SII) Pvt. Ltd, part of Cyrus Poonawalla Group, the world’s largest vaccine manufacturer, today…
-
Sudarshan Chemical launches Mobile Mammography Unit to enhance Early Cancer Detection in Ankleshwar
~ Pioneering Healthcare Access Initiatives in 28 Villages of Ankleshwar Taluka through Fully Equipped Mobile Screening Facility ~ Ankleshwar : Sudarshan Chemical Industries Limited (“SCIL” or “Company”), in collaboration with Deepak Foundation-Vadodara, has launched a Mobile…
-
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Paroxetine Extended-Release Tablets
Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Paroxetine Extended-Release Tablets USP, 25 mg and 37.5…
-
Table Space Reinforces Tech-First approach with the Launch of Meeting Rooms on its Workspace App
Enterprise-grade meeting rooms, backed by Table Space’s hospitality, are now accessible to businesses seeking high-quality workspace experiences. Bengaluru, India: Table Space, one of India’s leading workspace solutions providers, today announced the launch of Meeting Rooms…
-
Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer
Mumbai : Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM, “Alkem” and its subsidiaries) today announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment of HER2-positive breast cancer. Alkem’s…
Company profile
Konexio Network
Konexio Network helps our society with the daily business news updates, Corporate Interview, Article on Market and General Article which help our readers.
